NDC 73554-2111

Skysona

Elivaldogene Autotemcel

Skysona is a Intravenous Suspension in the Cellular Therapy category. It is labeled and distributed by Bluebird Bio, Inc.. The primary component is Elivaldogene Autotemcel.

Product ID73554-2111_22fb6d79-4f85-46ef-9ff2-443a74a38f27
NDC73554-2111
Product TypeCellular Therapy
Proprietary NameSkysona
Generic NameElivaldogene Autotemcel
Dosage FormSuspension
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-09-16
Marketing CategoryBLA /
Application NumberBLA125755
Labeler Namebluebird bio, Inc.
Substance NameELIVALDOGENE AUTOTEMCEL
Active Ingredient Strength30000000 1/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 73554-2111-1

1 SUSPENSION in 1 BAG (73554-2111-1)
Marketing Start Date2022-09-16
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Skysona]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SKYSONA
SKYSONA
98301155 not registered Live/Pending
bluebird bio, Inc.
2023-12-06
SKYSONA
SKYSONA
98301147 not registered Live/Pending
bluebird bio, Inc.
2023-12-06
SKYSONA
SKYSONA
98301127 not registered Live/Pending
bluebird bio, Inc.
2023-12-06
SKYSONA
SKYSONA
97229976 not registered Live/Pending
bluebird bio, Inc.
2022-01-20
SKYSONA
SKYSONA
97229967 not registered Live/Pending
bluebird bio, Inc.
2022-01-20
SKYSONA
SKYSONA
97229964 not registered Live/Pending
bluebird bio, Inc.
2022-01-20
SKYSONA
SKYSONA
97138015 not registered Live/Pending
bluebird bio, Inc.
2021-11-22
SKYSONA
SKYSONA
97132256 not registered Live/Pending
bluebird bio, Inc.
2021-11-18
SKYSONA
SKYSONA
79324824 not registered Live/Pending
Bluebird Bio (UK) Ltd
2021-03-08
SKYSONA
SKYSONA
79219837 5516212 Live/Registered
BLUEBIRD BIO, INC.
2017-08-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.